Sinopharm Group Co. Ltd. (1099.HK) HKSE

18.42

-0.22(-1.18%)

Updated at October 20 09:28AM

Currency In HKD

Valuation

Market Cap62.43B
Enterprise Value84.5B
P/E Ratio7.73
PEG Ratio-2.18
Price/Sales Ratio0.09
Price/Book Ratio0.65
Enterprise/Revenue0.17
Enterprise/EBITDA4.8

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin0.01
Operating Margin0.03

Management Effectiveness

Return On Assets0.02
Return On Equity0.09

Income Statement

Revenue584.51B
Revenue/Share184.85
Gross Profit44.26B
EBITDA20.17B
Net Income7.05B
Diluted EPS2.26

Balance Sheet

Total Cash47.16B
Total Cash/Share15.14
Total Debt93.29B
Total Debt/Equity1.16
Current Ratio1.34
Book Value Per Share41.56

Price History

52-Week Change-8.81
52-Week High22.35
52-Week Low16.74
Moving Average 50 Days18.82
Moving Average 200 Days19.07

Statistics

Average Volume5.74M
Shares Outstanding3.12B
% Held by Institutions0

Dividend And Splits

Trailing Annual Dividend Rate0.68
Trailing Annual Dividend Yield4.01
Payout Ratio0.71
Last Split FactorN/A
Last Split DateN/A